Status: Recruiting
"IL-1β Blockade to Prevent Immunothrombosis in Recipients of a Pancreatic Organ"
A prospective, open-label, uncontrolled, non-randomized, single-center Phase I/II clinical trial evaluating the safety of Anakinra in the immediate post-transplant period following pancreatic transplantation
Participants needed: 15
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Nantes University HospitalUpdated: Oct 13, 2026Locations: 2
Eligibility criteria
Patient admitted to Nantes University Hospital for a pancreatic transplant (alon... [+8]
Patient under guardianship/curatorship [+8]